Dexcom Inc (NASDAQ: DXCM) on Monday, soared 0.01% from the previous trading day, before settling in for the closing price of $82.93. Within the past 52 weeks, DXCM’s price has moved between $57.52 and $117.19.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 39.06%. The company achieved an average annual earnings per share of 23.64%. With a float of $386.61 million, this company’s outstanding shares have now reached $392.10 million.
Considering the fact that the conglomerate employs 10300 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 59.39%, operating margin of 15.25%, and the pretax margin is 17.62%.
Dexcom Inc (DXCM) Insider Activity
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of Dexcom Inc is 1.40%, while institutional ownership is 93.55%. The most recent insider transaction that took place on Jun 26 ’25, was worth 124,698. In this transaction EVP, Chief HR Officer of this company sold 1,466 shares at a rate of $85.06, taking the stock ownership to the 108,155 shares. Before that another transaction happened on Jun 26 ’25, when Company’s Officer proposed sale 1,466 for $85.06, making the entire transaction worth $124,698.
Dexcom Inc (DXCM) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.57 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 23.64% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 24.02% during the next five years compared to 39.06% growth over the previous five years of trading.
Dexcom Inc (NASDAQ: DXCM) Trading Performance Indicators
Dexcom Inc (DXCM) is currently performing well based on its current performance indicators. A quick ratio of 1.32 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.84. Likewise, its price to free cash flow for the trailing twelve months is 56.54.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.33, a number that is poised to hit 0.44 in the next quarter and is forecasted to reach 2.54 in one year’s time.
Technical Analysis of Dexcom Inc (DXCM)
Compared to the last year’s volume of 3.99 million, its volume of 3.16 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 45.71%.
During the past 100 days, Dexcom Inc’s (DXCM) raw stochastic average was set at 71.14%, which indicates a significant increase from 48.81% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 47.59% in the past 14 days, which was lower than the 49.63% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $82.80, while its 200-day Moving Average is $77.58. Nevertheless, the first resistance level for the watch stands at $83.66 in the near term. At $84.39, the stock is likely to face the second major resistance level. The third major resistance level sits at $84.97. If the price goes on to break the first support level at $82.36, it is likely to go to the next support level at $81.78. Should the price break the second support level, the third support level stands at $81.05.
Dexcom Inc (NASDAQ: DXCM) Key Stats
Market capitalization of the company is 32.52 billion based on 392,107K outstanding shares. Right now, sales total 4,033 M and income totals 576,200 K. The company made 1,036 M in profit during its latest quarter, and 105,400 K in sales during its previous quarter.
